According to The Insight Partners, Global Gastrointestinal Infection Testing Market size is projected to reach US$ 3,179.74 million by 2034 from US$ 1,610.84 million in 2025. The market is anticipated to register a CAGR of 7.85% during the forecast period 2026-2034.
The gastrointestinal infection testing market is witnessing robust expansion driven by the rising global burden of infectious diseases, increasing demand for rapid diagnostics, and continuous technological innovation in molecular testing platforms. The market’s growth trajectory reflects the increasing importance of early and accurate detection of pathogens responsible for gastrointestinal infections, including bacteria, viruses, and parasites.
Get a Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00002767
Gastrointestinal infections remain a major public health concern worldwide, particularly in emerging economies where sanitation and access to clean water remain limited. The growing prevalence of foodborne illnesses, rising international travel, and expanding urbanization are increasing exposure to infectious pathogens. Consequently, healthcare systems are investing in advanced diagnostic tools capable of delivering faster and more reliable results, which continues to accelerate the demand for gastrointestinal infection testing products and services.
One of the primary drivers of market growth is the increasing adoption of molecular diagnostic technologies. Polymerase chain reaction (PCR), multiplex testing panels, and next-generation sequencing (NGS) have revolutionized infectious disease detection by enabling simultaneous identification of multiple pathogens in a single test. These technologies reduce diagnostic turnaround time, improve accuracy, and support timely clinical decision-making. Healthcare providers are increasingly transitioning from traditional culture-based methods to molecular diagnostics due to their superior sensitivity and specificity.
Another major market driver is the rising global incidence of foodborne diseases. According to health organizations, millions of people suffer from food contamination-related infections each year, leading to significant economic and healthcare burdens. This has prompted governments and healthcare institutions to invest in better surveillance and testing infrastructure. Increasing consumer awareness regarding food safety and hygiene has also contributed to higher demand for routine testing, especially in hospitals, diagnostic laboratories, and food safety testing facilities.
Technological advancements in point-of-care (POC) testing are further boosting market growth. Rapid diagnostic kits that provide results within minutes are becoming essential tools in emergency departments, outpatient clinics, and rural healthcare settings. These tests enable immediate treatment decisions, reducing hospital stays and healthcare costs. The growing demand for decentralized healthcare and remote diagnostics is expected to significantly fuel the adoption of POC gastrointestinal infection testing solutions over the forecast period.
The growing geriatric population is another important factor driving the market. Elderly individuals are more susceptible to infections due to weakened immune systems and chronic comorbidities. Additionally, immunocompromised patients, including those undergoing chemotherapy or organ transplantation, require regular infection monitoring. The increasing size of these vulnerable patient populations continues to boost demand for accurate and routine gastrointestinal infection diagnostics.
Healthcare infrastructure improvements and increased healthcare spending in developing countries are also contributing to market expansion. Governments across Asia-Pacific, Latin America, and the Middle East are strengthening laboratory capabilities and expanding access to advanced diagnostic technologies. These initiatives are encouraging adoption of innovative testing solutions and expanding the customer base for diagnostic companies.
The rise of antimicrobial resistance (AMR) is another critical factor supporting market growth. Rapid identification of pathogens is essential for prescribing targeted antibiotic therapies and avoiding misuse of broad-spectrum antibiotics. Diagnostic testing plays a crucial role in combating AMR by enabling evidence-based treatment decisions. As awareness of antimicrobial stewardship grows, demand for rapid and accurate gastrointestinal infection tests is expected to rise significantly.
Increasing investments in research and development by diagnostic companies are accelerating innovation in the market. Companies are focusing on developing multiplex panels capable of detecting a broad range of pathogens in a single test. Automation and integration of artificial intelligence in diagnostic workflows are further enhancing laboratory efficiency and reducing human error.
Competitive Landscape and Key Players
The gastrointestinal infection testing market is highly competitive, with leading diagnostic companies focusing on product innovation, strategic partnerships, and global expansion. Major players operating in the market include:
- Abbott Laboratories
- Thermo Fisher Scientific
- bioMérieux
- Danaher Corporation
- QIAGEN
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Hologic, Inc.
These companies are investing heavily in molecular diagnostics, automation, and rapid testing technologies to strengthen their market positions and meet evolving healthcare demands.
Regional Outlook
North America currently holds a significant share of the gastrointestinal infection testing market due to advanced healthcare infrastructure, high awareness of infectious diseases, and strong presence of leading diagnostic companies. Europe follows closely, supported by government initiatives focused on disease surveillance and infection control. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period due to rising healthcare expenditure, increasing population, and expanding laboratory infrastructure.
Future Outlook
The future of the gastrointestinal infection testing market looks promising, with strong growth expected across all major regions. Continuous innovation in molecular diagnostics, expansion of point-of-care testing, and increasing awareness of infectious diseases will remain the key drivers shaping market growth through 2034. As healthcare systems worldwide prioritize early detection and prevention of infectious diseases, the demand for advanced gastrointestinal infection testing solutions is set to rise steadily.
Get Premium Research Report Market Size and Growth Report at:
https://www.theinsightpartners.com/buy/TIPRE00002767
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish